Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07762352
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude do AlcoitaoCompletedNot Applicable
NCT07762352Completed
Not Applicable
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude...
NCT07763249
Comparison of Paravertebral Versus Epidural Block for Post-thoracotomy Pain ControlHospital de Clinicas de Porto AlegreNot Yet RecruitingNot Applicable
NCT07763249Not Yet Recruiting
Not Applicable
Comparison of Paravertebral Versus Epidural Block for Post-thoracotomy Pain Cont...Hospital de Clinicas de P...
NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryFudan UniversityRecruitingPhase 3
NCT07762885Recruiting
Phase 3
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma...Fudan University
NCT07763665
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein ComplexAssiut UniversityNot Yet RecruitingPhase 4
NCT07763665Not Yet Recruiting
Phase 4
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Inju...Assiut University
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07763899
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763899Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762300
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary IncontinenceBenha UniversityRecruitingNot Applicable
NCT07762300Recruiting
Not Applicable
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary...Benha University
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07763106
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional CareSalus Care Center, Rybnik, PolandNot Yet RecruitingNot Applicable
NCT07763106Not Yet Recruiting
Not Applicable
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of P...Salus Care Center, Rybnik...
NCT07763704
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut UniversityNot Yet Recruiting
NCT07763704Not Yet Recruiting
—
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut University
NCT07764211
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health CenterNot Yet Recruiting
NCT07764211Not Yet Recruiting
—
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health Ce...
NCT07762482
Periodontal Tissue Stability After Surgical Correction of Altered Passive EruptionUniversity of Sao PauloRecruitingNot Applicable
NCT07762482Recruiting
Not Applicable
Periodontal Tissue Stability After Surgical Correction of Altered Passive Erupti...University of Sao Paulo
NCT07762326
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple SclerosisCairo UniversityNot Yet RecruitingNot Applicable
NCT07762326Not Yet Recruiting
Not Applicable
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders an...Cairo University
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 42 (10%)
Phase 21 (5%)
Phase 31 (5%)
Phase 11 (5%)